Effects of tryptophan depletion on the serotonin transporter in healthy humans. 2005

Nicole Praschak-Rieder, and Alan A Wilson, and Douglas Hussey, and Anna Carella, and Corie Wei, and Nathalie Ginovart, and Markus J Schwarz, and Johanna Zach, and Sylvain Houle, and Jeffrey H Meyer
Vivian M. Rakoff PET Imaging Centre, Centre for Addiction and Mental Health, and Department of Psychiatry, University of Toronto, Toronto, Canada.

BACKGROUND Lowering of brain serotonin by acute tryptophan depletion (TD) frequently leads to transient symptoms of depression in vulnerable individuals but not in euthymic healthy subjects with a negative family history of depression. The effects of TD on regional serotonin transporter binding potential (5-HTT BP), an index of 5-HTT density and affinity, were studied in healthy individuals using 3-(11)C-amino-4-(2-dimethylaminomethylphenylsulfanyl)benzonitrile ([11C]DASB) positron emission tomography (PET). Adaptive decreases in 5-HTT density and/or affinity during TD would be a possible compensatory mechanism to maintain sufficient extracellular serotonin levels during TD, thereby preventing a depressive relapse. METHODS Regional noninvasive 5-HTT BP was found in 25 healthy subjects using [11C]DASB PET. Fourteen subjects were scanned twice, once after TD and once after sham depletion, and 11 other healthy subjects were scanned twice to measure test-retest reliability of the method. RESULTS None of the healthy subjects experienced depressive symptoms during TD and there was no difference in regional 5-HTT BP during TD as compared with sham depletion. CONCLUSIONS Acute changes in 5-HTT density or affinity are unlikely to play a role in protecting healthy subjects against mood symptoms during TD. Other mechanisms that may be associated with greater resilience against acute lowering of extracellular serotonin should be explored to gain further insight into the neurochemical basis of different vulnerabilities to short-term depressive relapse.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001596 Benzylamines Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group. Phenylmethylamine,alpha-Aminotoluene,alpha Aminotoluene
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine

Related Publications

Nicole Praschak-Rieder, and Alan A Wilson, and Douglas Hussey, and Anna Carella, and Corie Wei, and Nathalie Ginovart, and Markus J Schwarz, and Johanna Zach, and Sylvain Houle, and Jeffrey H Meyer
August 2007, The international journal of neuropsychopharmacology,
Nicole Praschak-Rieder, and Alan A Wilson, and Douglas Hussey, and Anna Carella, and Corie Wei, and Nathalie Ginovart, and Markus J Schwarz, and Johanna Zach, and Sylvain Houle, and Jeffrey H Meyer
March 1999, Psychiatry research,
Nicole Praschak-Rieder, and Alan A Wilson, and Douglas Hussey, and Anna Carella, and Corie Wei, and Nathalie Ginovart, and Markus J Schwarz, and Johanna Zach, and Sylvain Houle, and Jeffrey H Meyer
January 2005, Biological psychiatry,
Nicole Praschak-Rieder, and Alan A Wilson, and Douglas Hussey, and Anna Carella, and Corie Wei, and Nathalie Ginovart, and Markus J Schwarz, and Johanna Zach, and Sylvain Houle, and Jeffrey H Meyer
November 2001, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Nicole Praschak-Rieder, and Alan A Wilson, and Douglas Hussey, and Anna Carella, and Corie Wei, and Nathalie Ginovart, and Markus J Schwarz, and Johanna Zach, and Sylvain Houle, and Jeffrey H Meyer
May 1993, The Journal of clinical endocrinology and metabolism,
Nicole Praschak-Rieder, and Alan A Wilson, and Douglas Hussey, and Anna Carella, and Corie Wei, and Nathalie Ginovart, and Markus J Schwarz, and Johanna Zach, and Sylvain Houle, and Jeffrey H Meyer
January 1991, Advances in experimental medicine and biology,
Nicole Praschak-Rieder, and Alan A Wilson, and Douglas Hussey, and Anna Carella, and Corie Wei, and Nathalie Ginovart, and Markus J Schwarz, and Johanna Zach, and Sylvain Houle, and Jeffrey H Meyer
October 2008, Psychopharmacology,
Nicole Praschak-Rieder, and Alan A Wilson, and Douglas Hussey, and Anna Carella, and Corie Wei, and Nathalie Ginovart, and Markus J Schwarz, and Johanna Zach, and Sylvain Houle, and Jeffrey H Meyer
February 2017, Translational psychiatry,
Nicole Praschak-Rieder, and Alan A Wilson, and Douglas Hussey, and Anna Carella, and Corie Wei, and Nathalie Ginovart, and Markus J Schwarz, and Johanna Zach, and Sylvain Houle, and Jeffrey H Meyer
April 2008, Acta neuropsychiatrica,
Nicole Praschak-Rieder, and Alan A Wilson, and Douglas Hussey, and Anna Carella, and Corie Wei, and Nathalie Ginovart, and Markus J Schwarz, and Johanna Zach, and Sylvain Houle, and Jeffrey H Meyer
February 1998, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Copied contents to your clipboard!